Esprinet S.p.A. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 4,690.95 million compared to EUR 4,491.61 million a year ago. Net income was EUR 44.18 million compared to EUR 31.41 million a year ago.

Basic earnings per share from continuing operations was EUR 0.89 compared to EUR 0.63 a year ago. Diluted earnings per share from continuing operations was EUR 0.88 compared to EUR 0.62 a year ago.